Reported sales nil
Net Loss of Kabra Drugs reported to Rs 0.06 crore in the quarter ended September 2022 as against net loss of Rs 0.03 crore during the previous quarter ended September 2021. There were no Sales reported in the quarter ended September 2022 and during the previous quarter ended September 2021.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
